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Mechanochemistry deals with reactions induced by the input of mechanical energy – for
example by impacts within a vibratory ball mill. The technique has a long history with
signiﬁcant contributions from Ostwald, Carey Lea and, notably, Faraday. Mechanochemistry
has subsequently seen application in a variety of areas of materials science including
mechanical alloying in metallurgy, the synthesis of complex organic molecules and, more
recently, the discovery and development of new solid forms of active pharmaceutical
ingredients. This paper overviews the broad areas of application of mechanochemistry,
some key features which make it a particularly attractive approach to materials synthesis
and some mechanistic aspects highlighted within the literature. A signiﬁcant part, however,
will focus on recent applications in the area of pharmaceuticals and its important role in
exploring the rich variety of solid forms available for small, drug-like, molecules.1. Introduction
Mechanochemistry is a long-established method for the synthesis of solids and
molecules. Its chemical importance was recorded by Faraday, who in 1820 demon-
strated the reduction of AgCl to Ag by grinding in a mortar and pestle a mixture of
AgCl and Zn.1 Signicant progress followed, especially through the work of Carey Lea
(1823–1897),2 and the position of mechanochemistry within the framework of
chemistry as a whole was established by Ostwald who noted the equivalency of
electrochemistry, thermochemistry, photochemistry and mechanochemistry.3–5
Long held as an eﬃcient process for the synthesis of metallic alloys, a recent
extensive review by James et al.6 has highlighted several of the emergent areas now
being actively pursued with regard to the application of mechanical energy in
driving various transformations – indeed a working denition from that review is
“mechanochemistry refers to reactions, normally of solids, induced by the impact
of mechanical energy such as grinding in ball mills”. A formal denition by IUPAC
states “a mechano-chemical reaction is a chemical reaction that is induced byDepartment of Chemistry, University of Cambridge, Lenseld Road, Cambridge, CB2 1EW, UK. E-mail: wj10@
cam.ac.uk
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 9
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View Article Onlinemechanical energy”.7 Although a narrow denition of mechanochemistry may
lead to a suggestion that the making and breaking of covalent bonds would be a
prerequisite for a process to fall under the denition of “mechanochemistry”,8
following the appreciation of the importance of “non-covalent bonds” in supra-
molecular chemistry it seems reasonable to include changes in crystal packing to
be a mechanochemical event. Links to mechanochemical activation by ultra-
sound have also been proposed.9,10
This paper will briey summarise recent developments in mechanochemistry,
particularly in its application in pharmaceutical materials science and its role in the
development of new solid drug dosage forms, to complement earlier literature
which has covered extensively metals and alloys and inorganic (ionic) systems. As
we will describe later, the amount of energy which can be imparted to a system
under mechanical activation can be signicant – certainly suﬃcient to break
chemical bonds6 – but can also be reduced when working with systems such as so
molecular crystals in order to minimise chemical activation while still enabling
processes such as the conversion of a crystalline solid to an amorphous product,11
or the readjustment of molecules within a lattice. Such readjustments may lead to
the introduction of lattice imperfections,12 to polymorphic transformations13 or to
the intimate mixing of two separate crystalline molecular solids to create a crys-
talline multicomponent product indistinct from that which would be obtained by a
conventional solution crystallisation.14 Particularly advantageous in mechano-
chemical transformations is the avoidance of the need for large volumes of solvent
(as required, for example, in the recrystallization of poorly soluble molecules), and
hence a strong “Green Chemistry” aspect tomechanochemistry is recognised.15,16 In
terms of commercial interest, the review by James et al. describes a search of patent
applications for the terms “mechanochemical” and “mechanochemistry” which
revealed a signicant increase in usage in the patent literature from 1980 onwards.62. Areas of application and development
The areas in which mechanochemistry has been applied with success are varied
and include: catalysts,17 nanoparticles,18–20 organic synthesis,21–27 MOFs,28
oxides,29 biomaterials,30,31 supramolecular chemistry,32–34 process engineering,35
dyes and pigments,36 uorophores,37 exfoliation of graphene nanosheets38 and
modication of fullerenes (see Fig. 1).39 Numerous further examples are given in
the review by James et al.6 and several other reviews on the application of
mechanochemistry are available.28,40–47 In particular, the contributions of V. V.
Boldyrev and his colleagues to both experimental and theoretical aspects of
mechanochemistry have been important to the subject.3,9,48,49
From a synthetic chemistry viewpoint an important observation is that
substances can react by a signicantly diﬀerent pathway in the solid state than
they would in solution, leading to new products or to much higher selectiv-
ities.50,51 This ability to generate a much broader product-spectrum, as we will
demonstrate later, is also particularly important in areas other than chemical
transformations e.g. in crystal polymorph conversions – and it is to be noted that
the addition of very small amounts of liquid may have a signicant impact on the
outcome of a solid–solid reaction, even though quantities are much less than a
conventional solvent-based reaction might require – see later.10 | Faraday Discuss., 2014, 170, 9–34 This journal is © The Royal Society of Chemistry 2014
Fig. 1 General scheme for the Heck reaction under ball milling conditions. Reproduced
from ref. 6.
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View Article OnlineA key area of active research remains the understanding of the processes by
which mechanically induced reactions occur.52 Given the variety of materials of
interest, ranging from metals and ceramics to pharmaceuticals, the specic
details of how a process occurs will likely be varied and complex.3,53,54 Also to be
distinguished is the time-scale over which an event is studied. During the few
milliseconds following the impact of two solids at high velocity, signicant local
consequences will ensue. Hot spots, magma–plasma regions, rapid induction of
defects (point, linear and planar) and then propagation of these defects through
the crystal are some of the concepts which have evolved. The distribution of
imparted energy will also be diﬀerent in those solids with high rigidity and few
pathways for energy dissipation (so that the eﬀects at the specic point of impact
will be great) than it is in those systems where structural movement (e.g. slippage
of crystal planes) may allow the energy (and its consequences) to be distributed
over a much larger distance.3 During this early stage, the making and breaking of
chemical bonds would seem possible. Following the initial short-term conse-
quences, there will also be the longer term events associated with the nal energy
dissipation and relaxation of the system. The slow crystallisation of an interme-
diate amorphous phase may be such an example (see Fig. 2 and 3).11,52,55,56 It is
possible, then, to envisage that an individual particle, for example within a milled
pharmaceutical material, may be completely amorphous initially, but over timeFig. 2 (a) Terahertz spectra obtained from (top to bottom): a 1 : 1 mesaconic acid–
phenazine cocrystal; mesaconic acid; phenazine. (b) Analysis (ex situ) of the extent of
formation of the cocrystal from a mixture of phenazine and mesaconic acid, as a function
of neat grinding time, as measured using the characteristic cocrystal band at 1.1 THz (red
circles). The blue star, by comparison, shows close to 100% conversion in 15 minutes as a
result of the presence of liquid in a LAG experiment. The blue square represents the
percentage of a cocrystal sample that remained crystalline during dry grinding.56
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 11
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View Article Onlinemay change to consist of domains of crystalline solid embedded within an
amorphous shell (or more likely vice versa where, for example, humidity from the
surrounding atmosphere results in each amorphous particle crystallising from
the outside). This model might suggest that a description of a product as 25%
amorphous does not mean that 25% of all the particles are amorphous and 75%
are not – but that each individual particle within the product consists of domains
of crystalline and amorphous in a 3 : 1 ratio.
A key factor for potential commercial exploitation in many instances would
seem to be diﬃculties associated with scale-up. The progression from gram-scale,
lab-based synthesis to kilogram-scale or higher outputs is an issue that has been
addressed in many industrial applications3 and more recently in the area of
pharmaceuticals, where twin extrusion approaches are employed (Fig. 4).57,58
Furthermore, it is noteworthy that frequently the generation of a new material
(e.g. in the case of molecular crystals) at the gram level can allow, through
subsequent seeding of a supersaturated solution, production via a conventional
solvent-based crystallisation route.59
It is also necessary to recognise the need for methods of structurally charac-
terising the products of mechanochemical processes. When applied to chemical
conversions which may occur, molecular identity can be established by conven-
tional analytical methods (e.g. solution NMR and mass spectrometry). For solid–
solid transformations, where the identity of crystalline intermediates or nal states
is required, major improvements in crystal structure determination from powder X-
ray diﬀraction data (frequently coupled with solid-state NMR) have been pivotal.60–64
In addition, the structural analysis of individual crystallites that result from
mechanochemical processes is possible through utilisation of the electron
diﬀraction facility of the transmission electron microscope.65–67Fig. 3 (a) Schematic of the diﬀerent pathways occurring during the mechanochemical
treatment of sulphathiaziole. Mechanical treatment resulted in the partial amorphisation of the
drug and the interconversion of Forms I and II. (b) Time proﬁle for the phase interconversion for
sulphathiazole: 1– indicating generation of Form I; 2– initial loss and subsequent regeneration
of Form III; 3 – the existence of a transient amorphous phase. Figure adapted from ref. 55.
12 | Faraday Discuss., 2014, 170, 9–34 This journal is © The Royal Society of Chemistry 2014
Fig. 4 Typical twin extrusion conﬁguration used for the formation of cocrystals. The
conveying and mixing zones are shown. Typical output rate is approximately 0.5 g min1.
PXRD suggests comparable properties for the product to that obtained by conventional
solution growth. The possibility of simultaneously blending the cocrystal product within a
polymermatrix is an important additional advantage of themethod. Reproduced from ref. 58.
Paper Faraday Discussions
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
2 
Se
pt
em
be
r 2
01
4.
 D
ow
nl
oa
de
d 
on
 0
5/
08
/2
01
5 
14
:5
1:
19
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online3. Pharmaceutical materials
Within various areas of process engineering (including food science, chemicals
and pharmaceuticals) particle size reduction is an important step.35,68 Approaches
to size reduction include compression (e.g. rollers) or impact (e.g. impact mills
and ball mills). All methods involve transfer of varying amounts of energy to theFig. 5 Demonstration of the amorphisation of trehelose as a result of milling at room
temperature within a high energy planetary micro-mill. PXRD patterns (a) before and (b)
after milling. Adapted from ref. 11.
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 13
Fig. 6 (a) Grinding-time dependence of the FTIR spectra for famotidine showing from top
to bottom the emergence of the absorption at 3451 cm1 which is used to monitor the
formation of Form A of the material. (b) Plot of peak intensity ratio (I3451/I3505) for the
spectra above indicating a possible zero order rate law for the conversion. Reproduced
from ref. 78 with permission from Elsevier.
Faraday Discussions Paper
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View Article Onlineparticle(s), and as a result other consequences can accompany the size reduction
including the introduction of defects (such as dislocations, point defects and
stacking faults)12 and in particular amorphisation69 or polymorphic
transformations.70
The work of Descamps and others with regard to pharmaceutical materials has
clearly demonstrated the critical role of the glass transition temperature, Tg, in
determining whether or not a persistent amorphous phase will be gener-
ated.11,71–73 The combination of increased milling intensity and the absence of any
plasticisers, which might lower Tg (either as liquid or vapour, e.g. water, from the
surrounding atmosphere), will encourage the formation of an amorphous
product (Fig. 5). The distinction between amorphous and crystalline products is
particularly important for pharmaceutical applications given the inherent
increased transient solubility (and hence improved bioavailability) associated
with amorphous compared to crystalline solid forms.69,74–76
Frequently, the amorphisation of a material can be a desirable outcome,
especially as a means of increasing the transient solubility of the material or of
eliminating compression issues with the crystalline equivalent.68 This attribute is
frequently used in the pharmaceutical industry, and the complex nature of the
resulting solids has been extensively studied (especially with regard to the
instability of the amorphous form with respect to the crystalline state).74
Polymorphic transformations from the stable to a metastable form (again with
increased apparent solubility) can also be a useful consequence of the application
of mechanical energy (Fig. 6).13,77–79 Jet-milling, a particle-size reduction method
frequently used within the pharmaceutical industry where particle–particle
collisions occur within a carrier gas (typically air), has, for example, been found to
induce polymorph interconversions along with the size reductions.Fig. 7 Schematic of the observed transformations between the three polymorphic forms
of anthranilic acid with the pathways depending on the conditions under which mecha-
nochemical treatment was performed.
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 15
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View Article OnlineWith grinding experiments, an approach for directing the polymorphic
outcome through addition of a small amount of liquid was described by Trask
et al. for the cases of anthranilic acid and succinic acid (see Fig. 7).80 For
anthranilic acid, interconversion between the three known polymorphic forms
occurred depending upon the choice of the added liquid.81 In the case of succinic
acid, while the b-polymorph appeared stable to neat grinding, addition of a few
drops of a low polarity liquid (e.g. hexane) caused conversion to the a-polymorph.
More polar liquids (e.g. water, acetonitrile or methanol) appeared not to induce
the transformation. The actual mechanism of the solid–solid transformation is an
area of ongoing interest, especially where the change appears to be crystal–crystal
in nature.82
An additional reason for interest in mechanochemical processes comes from
the fact that the majority of drugs (80–90%) are formulated as tablets, which are
seen as a reliable and general way of delivering medicines, and that the tableting
process itself requires the application of signicant applied pressures (see
Fig. 8).55,83–90 Importantly, tablets contain other components (excipients), which
are added to enhance performance e.g. lubricants, dissolving agents and so on.
When pressure is applied during compression, there is a risk that surface–surface
reactions between the components and drug, such as that between dicalcium
phosphate dihydrate and aspirin, will lead to enhanced instability.91
More recent interest has focused on the formation of cocrystals (see Fig. 9) by
milling or grinding.92–94 One of the earliest examples of a cocrystal obtained by
grinding is that of quinhydrone reported in the work of Wohler published in
1844.95 The advantage for this system compared to solution crystallization was
shown by Patil et al.,96 who demonstrated that simple grinding of mixtures was
signicantly superior to attempted solution growth, where self oxidation–reduc-
tion lowered the eﬃciency of complex formation. Subsequently, numerous
examples of host–complex formation by solid–solid mixing were reported by Toda
and co-workers.50 Work by Etter and colleagues also demonstrated how solid–
solid grinding could be used to produce hydrogen bonded cocrystals of adenine
and thymine derivatives, where a marked selectivity amongst various base pairs
was observed.14 Hollingsworth et al.51 used grinding as a means of creating coc-
rystals of dinitriles and urea, as part of a wide study of inclusion crystals, in cases
where solution growth was not possible. Pedireddi et al. demonstrated that inFig. 8 (a) Hydrostatic pressure induced transition for chlorpropamide in a saturated
ethanol solution. The phase change results in a ﬁrst order change at approximately 3.5
GPa. The change is illustrated for the a-axis. (b) Changes in non-hydrogen atom positions
as the transition pressure is reached. Adapted from ref. 46.
16 | Faraday Discuss., 2014, 170, 9–34 This journal is © The Royal Society of Chemistry 2014
Fig. 9 Schematic of the characteristics of polymorphs and multicomponent systems.
Cocrystals represent a sub-set of the multicomponent group, frequently that charac-
terised by the requirement that the components be neutral and solid at room temperature.
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View Article Onlinesome cases a third component is necessary in order for a cocrystallisation reac-
tion to take place97 and Kuroda and her colleagues studied the inuence of the
addition of a third component on the optical properties of the resulting
cocrystals.98
Frequently, the solid state properties of a pure drug can present processing or
application problems e.g. particle ow, thermal stability, stability to moisture or
ability to be compacted,68 and, increasingly, poor solubility is an issue.99,100 The
challenge with a badly behaving drug, therefore, is to be able to control the
properties of the molecule in the solid state without recourse to chemical
modication by covalent chemistry. The use of multicomponent systems, espe-
cially pharmaceutical cocrystals, andmore recently ionic cocrystals,101,102 has been
demonstrated to be an eﬀective strategy in such instances.103–112 In terms of
property improvement with pharmaceutical cocrystals, various examples are
known including: enhancing stability against hydration of an anhydrate form (seeFig. 10 Supramolecular synthon approach used in the design of cocrystals of caﬀeine
with various dicarboxylic acids. This approach lead to a variety of solid forms of caﬀeine
which could be tested for stability under conditions of high humidity. Mechanochemistry
was the technique used to both screen for cocrystal formation and also prepare powders
for humidity assessment.
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 17
Fig. 11 Packing diagrams for Form I and Form II paracetamol. Whilst Form I is the stable
phase it does not compress well during tablet formation. The metastable Form II has a
layered structure more appropriate for compression, but readily transforms to Form I.
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View Article OnlineFig. 10),113–116 developing forms with improved compression properties (for tablet
formation) (see Fig. 11 and 12),117,118 signicantly improving the bioavailability of
poorly soluble drugs and controlled release strategies e.g. for insulin.119 Trask has
reported on the potential intellectual property implications of pharmaceutical
cocrystals,120 and recent interest has also focused on regulatory guidelines.121 In
non-pharmaceutical applications, benets of cocrystallisation have been shown
for uorescent materials37,122 and explosives.123,124
An early indication of the potential to form pharmaceutical cocrystals by
grinding was provided by Caira et al. in 1995 who used grinding to prepare a series
of crystalline products containing sulfonamide (similar to those obtained from
solution) in a facile manner.125 They also reported detailed solid state kinetic data
based on powder X-ray measurements and were able to show a distinct selectivity
between reactants during grinding.
An ongoing challenge, however, is selecting possible coformers which might
cocrystallise with the API rather than remain as a separate and distinct crystalline
phase. Whilst various strategies have been developed to predict the likelihood of
cocrystal formation,126–129 experimental screening for viable coformers remains
vital (Fig. 13).130–132 While solution growth remains the ideal approach – especially
with regard to scale-up in later stages of development – signicant diﬀerences in
solubility between the drug and coformer oen presents diﬃculties.115,116,133–135
Mechanochemistry has emerged as a powerful tool in the experimental screening
area, and has the advantage of minimising the need for large volumes of solvent
(Fig. 14). It has also emerged as a powerful way of searching for diﬀerentFig. 12 Micrographs of tablets made from (a) paracetamol Form I and (b to d) cocrystals of
paracetamol with theophylline, naphthalene and oxalic acid respectively. Tablet (a) is
poorly formed as a result of the inappropriate packing of the molecules in the lattice,
whereas the cocrystal structures are amenable to deformation during tableting.118
18 | Faraday Discuss., 2014, 170, 9–34 This journal is © The Royal Society of Chemistry 2014
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View Article Onlinepolymorphic forms of cocrystals135,136 as well as for various stoichiometric
compositions e.g. 1 : 1, 1 : 2 and 2 : 1.59 Furthermore, mechanochemistry has
been used to identify chiral agents suitable for converting a racemate into two
distinct diastereomeric cocrystal phases137 as well as for coformer exchange.138
An extension to simple (i.e. neat or dry) grinding of mixtures was reported by
Shan et al.who added a few drops of liquid to the reactionmixture (liquid assisted
grinding, LAG) (see Fig. 15).139 Initial attention focused on LAG as a means of
accelerating cocrystallisation kinetics, although it was subsequently shown to
provide a means of increasing product diversity. For example, the outcome of
mechanochemical formation of cocrystals has been compared with that from
using other approaches to cocrystallsation. Trask et al. reported three possibleFig. 13 The use of mechanochemistry to explore the various possible combinations of
coformers for a family of steroid drugs. The various outcomes are delineated by the
accompanying legend. See ref. 161 for details.
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 19
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View Article Onlineoutcomes in the case of cocrystals with caﬀeine: (i) solution growth and milling
produced identical products; (ii) a diﬀerent stoichiometric product could be
obtained by milling compared to solution; and (iii) diﬀerent polymorphic forms
were possible.59 Numerous recent publications have demonstrated that LAG is
likely to be the most eﬃcient way of screening for cocrystal formation.140–144 The
key advantage of LAG over solution based approaches was interpreted by
Davey,145,146 Childs147 and others148 on the basis of solution phase chemistry
(Fig. 16). Other developments, such as ion- and liquid-assisted grinding (ILAG)149
and vapour digestion of solid mixtures,150,151 have also been reported.
Further insight has been given by the recent work of Bucˇar et al. for the case of
caﬀeine and benzoic acid.152 No cocrystals for this pair of molecules were known
despite a strong expectation based on studies of analogous systems153 and despite
extensive experimental eﬀorts to generate such a species over many years. A
systematic study using a large range of cocrystallisation methods including neat
grinding, liquid assisted grinding, melt crystallization and various solution
methods was employed (Fig. 17). All failed to produce the elusive cocrystal even
though theoretical work had clearly conrmed a cocrystal was thermodynamically
feasible. During grinding experiments, however, the addition of a few seed crys-
tals of an isostructural uorobenzoic acid cocrystal readily generated the elusive
cocrystal, with the inference being that, as in solution crystallisation, a high
barrier to nucleation of a particular form can frequently exist.Fig. 14 Overview of the results obtained by various cocrystallisation attempts for pirox-
icam. Solvent-drop grinding (LAG) is shown in this case to be the most eﬃcient and
straightforward screening method. The numbers 1–5 indicate the various solvents used in
the experiments. Reproduced with permission from ref. 142.
20 | Faraday Discuss., 2014, 170, 9–34 This journal is © The Royal Society of Chemistry 2014
Fig. 15 Demonstration of the enhanced kinetics of cocrystal formation upon addition of a
few drops of methanol to the grinding jar. PXRD patterns for (a) tetracarboxylic acid, (b)
bipyridyl, (c) outcome of neat grinding for 60 minutes (as the sum of the reactants), (d) the
product obtained when a few drops of methanol are added and (e) the simulated pattern
for the cocrystal.
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View Article OnlineAccompanying the recent developments in mechanochemistry has been the
development of techniques to follow the course of solid–solid reactions using
both ex situ and in situ approaches.56,122,154–158 Ex situ analysis has frequently
suggested that there may be distinct intermediates generated (Fig. 18).154,159 The
application of synchrotron X-ray diﬀraction for in situ studies has indeed
conrmed the presence of crystalline intermediates and a possible role of
amorphous phases.157 To better understand the processes occurring duringFig. 16 Typical three-component phase diagrams contrasting (a) congruent and (b)
incongruent solubility proﬁles indicating the diﬃculties which will arise during conven-
tional evaporative solution growth crystallisation. The fact that LAG experiments, with
minimal amounts of solvent present, places the system close to the cocrystal composition
illustrates the ability of LAG to form cocrystals when solids of very diﬀerent solubility are
investigated. Reproduced from ref. 34.
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 21
Fig. 17 Top. Isostructural cocrystals of caﬀeine with various ﬂuorobenzoic acids which
have similar packing to that predicted for the likely structure of the caﬀeine–benzoic acid
cocrystal. Bottom. PXRD traces of (a) product without deliberate addition of seeds, but
prepared in an environment where the caﬀeine–benzoic acid cocrystal had previously
been obtained, (b) products of various seeding reactions, (c) products of various unseeded
reactions, (d) benzoic acid and (e) caﬀeine. Themain points to note include the similarity of
the patterns in (a) and (b) and that those in (c) are a simple combination of the starting
materials in (d) and (e). See ref. 152 for more details.
Fig. 18 The discrete trimer units and extended polymer chains (based on halogen bond
interactions) believed to be formed during the LAG reaction. When the strength of the
halogen bond is weak the product is limited to the trimer unit.
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View Article Online
Fig. 19 In situ synchrotron data for the milling of suberic acid and nicotinamide in a 2 : 1
ratio. (a) The PXRD patterns of the phases expected to be formed during milling along with
the data obtained as a function of time. The inset shows the particular region at 0.4 to 0.5
degrees two-theta showing the initial formation of the 1 : 1 cocrystal followed by the 2 : 1
product. (b) The speciﬁc reﬂections indicated by arrows indicate the intermediate phase
which is not detected by conventional ex situ studies. See ref. 157 for further details.
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View Article Onlinemilling, several recent eﬀorts have concerned developingmethods to follow in situ
the course of the reaction. Noteworthy has been the use of synchrotron X-ray
diﬀraction. In a study of the milling of a mixture of carbamazepine and succinicThis journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 170, 9–34 | 23
Fig. 20 (a) Transmission electronmicrograph and (b) electron diﬀraction pattern obtained
from a sample of a theophylline:L-malic acid cocrystal prepared by LAG. The method is
able to monitor particle size as well as polymorphic form.160
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View Article Onlineacid, Halasz et al.157 showed that, in the absence of any added liquid, the outcome
was the gradual disappearance of reections of the two components and apparent
amorphisation. A similar experiment, but now with the addition of 50 mL of
acetonitrile showed that within 10 seconds of milling, reections associated with
a triclinic (cbz)(sac) cocrystal emerged. The reaction was complete within 4
minutes. Such rapidity was to be compared with other solid–solid grinding
systems (e.g. the reaction of ZnO with imidazoles) where reaction timescales were
much longer. Similar in situ studies were conducted for suberic acid and nico-
tinamide demonstrating that formation of a 2 : 1 cocrystal during grinding
proceeds via a 1 : 1 cocrystal intermediate (see Fig. 19). Friˇscˇic´ and his colleagues
have also used in situ methods, based on the changes in uorescence122 accom-
panying cocrystallisation, to monitor directly events within the grinding jar.4. Concluding remarks
In the case of pharmaceutical solids, recent work using atomic force microscopy
(AFM), terahertz spectroscopy and transmission electron microscopy (TEM)
suggests that these techniques will be important for characterising mechanically
treated samples and understanding changes which occur during such processing.
For example, there are particle–particle eﬀects – especially important during
compression in a tablet containing various components. In the case of aspirin
(acetylsalicylic acid) and dicalcium phosphate, when the excipient was attached to
the tip of the AFM cantilever and diﬀerent pressures and contact times under
various humidity conditions there was evidence for enhanced reactivity induced by
surface contact with excipient.91 Terahertz spectroscopy has emerged as a sensitive
method of monitoring changes in the solid form during mechanical activation,56,156
whereas TEM has been shown to be a powerful technique for characterising the size
and shape of particulates generated mechanochemically, as well as determining
their crystal form (see Fig. 20). TEM can also be used to identify defects in phar-
maceutical crystals (see Fig. 21), and will enable a greater understanding of how
defects introduced into crystals during mechanical processing inuence material
properties – for example a link between defects in theophylline crystals and crystal
fracture has been established.16024 | Faraday Discuss., 2014, 170, 9–34 This journal is © The Royal Society of Chemistry 2014
Fig. 21 Extensive network of dislocations in a sample of theophylline as revealed by
transmission electron microscopy. In general, such dislocations can result from the
mechanical treatment of crystals.
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View Article OnlineMechanochemistry, as mentioned at the outset, provides many opportunities for
developing environmentally-friendly processes (especially the avoidance of large
volumes of solvent). It also provides routes tomaterials not readily obtained by other
methods. It has a long history and no doubt will continue to demonstrate useful
applications whilst at the same time generate considerable activity in rationalising
the mechanistic aspects behind the many types of transformations observed.References
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